Free tool
Medicare drug spending
Last checked: Nov 20, 2026Latest source record: 2024 calendar yearSource: CMS (Medicare Part D Spending by Drug : 2024-01-01; Medicare Part B Spending by Drug : 2024-01-01)Methods & limitations
Part D, 2024
$288.7B
Gross drug spending in the dataset
Part B, 2024
$60.8B
Gross drug spending in the dataset
Drugs listed
11
Part D and Part B
Total spending by year
- Part D
- Part B
View as table
| Year | Part D | Part B |
|---|---|---|
| 2020 | $194,092,038,339 | $37,778,829,680 |
| 2021 | $213,513,349,361 | $40,135,340,775 |
| 2022 | $239,779,215,689 | $44,241,259,745 |
| 2023 | $275,808,918,753 | $50,775,853,083 |
| 2024 | $288,667,842,058 | $60,838,164,403 |
Top 11 by total spending
2024 figures. Growth compares with 2023. Per-beneficiary ranks skip drugs with fewer than 11 beneficiaries.
| Drug | Part | Spending | Change | Beneficiaries | Per beneficiary | Per unit |
|---|---|---|---|---|---|---|
| Ciprofloxacin-Dexamethasone Ciprofloxacin HCl/Dexameth | D | $34.7M | -6% | 240,723 | $144 | $14.79 |
| Ciprofloxacin HCl* Ciprofloxacin HCl | D | $32.7M | -16% | 3,541,526 | $9 | $0.55 |
| Cipro HC Ciprofloxacin/Hydrocortisone | D | $3.7M | +19% | 9,059 | $410 | $36.56 |
| Ciloxan Ciprofloxacin HCl | D | $1.5M | +4% | 3,881 | $391 | $75.76 |
| Cipro Ciprofloxacin | D | $383K | -3% | 1,807 | $212 | $1.47 |
| Ciprofloxacin-D5W Ciprofloxacin In 5 % Dextrose | D | $72K | +4% | 767 | $94 | $0.03 |
| Ciprodex Ciprofloxacin HCl/Dexameth | D | $62K | -99% | 264 | $235 | $29.60 |
| Cipro Ciprofloxacin HCl | D | $38K | +34% | 273 | $141 | $5.34 |
| Ciprofloxacin HCl-Fluocinolone Ciprofloxacin HCl/Fluocinolone | D | $9K | -73% | 35 | $255 | $15.11 |
| Ciprofloxacin Ciprofloxacin | D | $3K | n/a | 12 | $282 | $2.52 |
| Cipro I.V.* Ciprofloxacin In 5 % Dextrose* · J0744 | B | $3K | +23% | 525 | $6 | $2.20 |
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.